|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.51 USD | -1.34% |
|
-0.95% | -21.22% |
| Apr. 25 | Top Premarket Gainers | MT |
| Apr. 25 | North American Morning Briefing : More Tech -2- | DJ |
Cidara Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was USD 63.91 million compared to USD 64.45 million a year ago. Net loss was USD 22.93 million compared to USD 33.58 million a year ago.
Basic loss per share from continuing operations was USD 5.25 compared to USD 9.61 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.22% | 57.84M | |
| -1.43% | 103B | |
| +8.96% | 101B | |
| +4.40% | 23.07B | |
| -12.15% | 22.23B | |
| -4.36% | 18.05B | |
| -39.98% | 17.18B | |
| -10.04% | 16.94B | |
| +6.79% | 14.07B | |
| +38.61% | 12.35B |
CIDARA THERAPEUTICS, INC. 
